Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liese, A. M.
Right arrow Articles by Spolarics, Z.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liese, A. M.
Right arrow Articles by Spolarics, Z.
(Journal of Leukocyte Biology. 2001;70:289-296.)
© 2001 by Society for Leukocyte Biology

Augmented TNF-{alpha} and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes

Amy M. Liese*, Muhammad Q. Siddiqi*, John H. Siegel*, Thomas Denny{dagger} and Zoltán Spolarics*

Departments of
* Anatomy, Cell Biology & Injury Sciences, and
{dagger} Pediatrics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey

Correspondence: Zoltán Spolarics, M.D., Ph.D., Associate Professor, UMDNJ-New Jersey Medical School, 185 South Orange Ave., MSB G-626, Newark, NJ 07103. E-mail: spolaric{at}umdnj.edu

The presence of dysfunctional/damaged red blood cells (RBCs) has been associated with adverse clinical effects during the inflammatory response. The aim of this study was to elucidate whether oxidatively modified, autologous RBCs modulate monocyte cytokine responses in humans. Monocyte tumor necrosis factor {alpha} (TNF-{alpha}) and IL-10 production was measured in whole blood from healthy volunteers using ELISA and flow cytometry. Oxidatively modified RBCs (15 mM phenylhydrazine, 1 h, OX-RBC) or vehicle-treated RBCs (VT-RBC) opsonized by autologous serum were administered alone or in combination with one of three priming agents: E. coli lipopolysaccharide (LPS, 0.2 ng/ml), zymosan A (1 mg/ml), or phorbol 12-myristate 13-acetate (PMA, 50 ng/ml). OX-RBC or VT-RBC alone did not result in the release of TNF-{alpha} or IL-10. LPS, zymosan, and PMA caused marked and dose-dependent increases in TNF-{alpha} and IL-10 production. Addition of OX-RBC augmented the LPS-, zymosan-, and PMA-induced TNF-{alpha} release by approximately 100%. OX-RBC augmented LPS- and zymosan-induced IL-10 release by 400–600%. Flow cytometry analyses showed that monocytes were responsible for TNF-{alpha} and IL-10 production in whole blood. The presence of OX-RBC alone increased the complexity of CD14+ monocytes but caused no cytokine production. LPS alone induced cytokine production without altering cell complexity. After the combined (OX-RBC+LPS) treatment, monocytes of high complexity were responsible for TNF-{alpha} production. The presence of mannose or galactose (at 10–50 mM) did not alter the observed augmentation of cytokine production by OX-RBC, suggesting that lectin receptors are not involved in the response. These studies indicate that the interaction between damaged autologous erythrocytes and monocytes has a major impact on the cytokine responses in humans. An augmented cytokine production by the mononuclear phagocyte system may adversely affect the clinical course of injury and infections especially in genetic or acquired RBC diseases or after transfusions.

Key Words: red blood cells • cytokines • oxidative stress • macrophage • host response • inflammation




This article has been cited by other articles:


Home page
J. Immunol.Home page
Z. Du, E. Kelly, I. Mecklenbrauker, L. Agle, C. Herrero, P. Paik, and L. B. Ivashkiv
Selective regulation of IL-10 signaling and function by zymosan.
J. Immunol., April 15, 2006; 176(8): 4785 - 4792.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Spolarics, M. R. Condon, M. Siddiqi, G. W. Machiedo, and E. A. Deitch
Red blood cell dysfunction in septic glucose-6-phosphate dehydrogenase-deficient mice
Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2118 - H2126.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
A. Salvador and M. A. Savageau
Quantitative evolutionary design of glucose 6-phosphate dehydrogenase expression in human erythrocytes
PNAS, November 25, 2003; 100(24): 14463 - 14468.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. R. Condon, J. E. Kim, E. A. Deitch, G. W. Machiedo, and Z. Spolarics
Appearance of an erythrocyte population with decreased deformability and hemoglobin content following sepsis
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2177 - H2184.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the Society for Leukocyte Biology.